Effects of surfactant treatment in late preterm infants with respiratory distress syndrome

Carlo Dani, Fabio Mosca, Giovanni Vento, Paolo Tagliabue, Simonetta Picone, Gianluca Lista, Vassilios Fanos, Simone Pratesi, Luca Boni

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate surfactant effectiveness for the treatment of respiratory distress syndrome (RDS) in late preterm infants. Methods: We performed a retrospective cohort study of infants born between 34+0 and 36+6 weeks of gestation admitted for respiratory failure in seven perinatal centers from January 2010 to December 2014. We evaluated changes of FiO2, PaO2 and a/APO2 in surfactant-treated patients, and the need and duration of MV, the duration of noninvasive respiratory support, stay in NICU and in hospital in surfactant-treated and untreated late preterm infants with RDS alone. Results: We studied 562 infants with RDS, 252 (45%) were treated with surfactant and 310 (55%) were not. FiO2, PaO2 and a/APO2 significantly improved after surfactant treatment. The adjusted odds ratio for the need of MV and the adjusted differences of duration of noninvasive respiratory support, and of NICU and hospital stay were not different in the surfactant and non-surfactant groups. Conclusions: Surfactant therapy was followed by a quick and persisting significant improvement of respiratory function in late preterm infants with RDS. Surfactant did not improve short-term outcomes in our population probably because other factors such as the gestational age, occurrence of complications and poor feeding play a relevant role.

Original languageEnglish
Pages (from-to)1259-1266
Number of pages8
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume31
Issue number10
DOIs
Publication statusPublished - May 19 2018

Fingerprint

Newborn Respiratory Distress Syndrome
Premature Infants
Surface-Active Agents
Therapeutics
Respiratory Insufficiency
Gestational Age
Length of Stay
Cohort Studies
Retrospective Studies
Odds Ratio
Pregnancy

Keywords

  • infant
  • Late preterm
  • respiratory distress syndrome
  • surfactant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Effects of surfactant treatment in late preterm infants with respiratory distress syndrome. / Dani, Carlo; Mosca, Fabio; Vento, Giovanni; Tagliabue, Paolo; Picone, Simonetta; Lista, Gianluca; Fanos, Vassilios; Pratesi, Simone; Boni, Luca.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 31, No. 10, 19.05.2018, p. 1259-1266.

Research output: Contribution to journalArticle

Dani, C, Mosca, F, Vento, G, Tagliabue, P, Picone, S, Lista, G, Fanos, V, Pratesi, S & Boni, L 2018, 'Effects of surfactant treatment in late preterm infants with respiratory distress syndrome', Journal of Maternal-Fetal and Neonatal Medicine, vol. 31, no. 10, pp. 1259-1266. https://doi.org/10.1080/14767058.2017.1313828
Dani, Carlo ; Mosca, Fabio ; Vento, Giovanni ; Tagliabue, Paolo ; Picone, Simonetta ; Lista, Gianluca ; Fanos, Vassilios ; Pratesi, Simone ; Boni, Luca. / Effects of surfactant treatment in late preterm infants with respiratory distress syndrome. In: Journal of Maternal-Fetal and Neonatal Medicine. 2018 ; Vol. 31, No. 10. pp. 1259-1266.
@article{b0bf2ce758a54791939a54a0317a35bc,
title = "Effects of surfactant treatment in late preterm infants with respiratory distress syndrome",
abstract = "Objective: To evaluate surfactant effectiveness for the treatment of respiratory distress syndrome (RDS) in late preterm infants. Methods: We performed a retrospective cohort study of infants born between 34+0 and 36+6 weeks of gestation admitted for respiratory failure in seven perinatal centers from January 2010 to December 2014. We evaluated changes of FiO2, PaO2 and a/APO2 in surfactant-treated patients, and the need and duration of MV, the duration of noninvasive respiratory support, stay in NICU and in hospital in surfactant-treated and untreated late preterm infants with RDS alone. Results: We studied 562 infants with RDS, 252 (45{\%}) were treated with surfactant and 310 (55{\%}) were not. FiO2, PaO2 and a/APO2 significantly improved after surfactant treatment. The adjusted odds ratio for the need of MV and the adjusted differences of duration of noninvasive respiratory support, and of NICU and hospital stay were not different in the surfactant and non-surfactant groups. Conclusions: Surfactant therapy was followed by a quick and persisting significant improvement of respiratory function in late preterm infants with RDS. Surfactant did not improve short-term outcomes in our population probably because other factors such as the gestational age, occurrence of complications and poor feeding play a relevant role.",
keywords = "infant, Late preterm, respiratory distress syndrome, surfactant",
author = "Carlo Dani and Fabio Mosca and Giovanni Vento and Paolo Tagliabue and Simonetta Picone and Gianluca Lista and Vassilios Fanos and Simone Pratesi and Luca Boni",
year = "2018",
month = "5",
day = "19",
doi = "10.1080/14767058.2017.1313828",
language = "English",
volume = "31",
pages = "1259--1266",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Effects of surfactant treatment in late preterm infants with respiratory distress syndrome

AU - Dani, Carlo

AU - Mosca, Fabio

AU - Vento, Giovanni

AU - Tagliabue, Paolo

AU - Picone, Simonetta

AU - Lista, Gianluca

AU - Fanos, Vassilios

AU - Pratesi, Simone

AU - Boni, Luca

PY - 2018/5/19

Y1 - 2018/5/19

N2 - Objective: To evaluate surfactant effectiveness for the treatment of respiratory distress syndrome (RDS) in late preterm infants. Methods: We performed a retrospective cohort study of infants born between 34+0 and 36+6 weeks of gestation admitted for respiratory failure in seven perinatal centers from January 2010 to December 2014. We evaluated changes of FiO2, PaO2 and a/APO2 in surfactant-treated patients, and the need and duration of MV, the duration of noninvasive respiratory support, stay in NICU and in hospital in surfactant-treated and untreated late preterm infants with RDS alone. Results: We studied 562 infants with RDS, 252 (45%) were treated with surfactant and 310 (55%) were not. FiO2, PaO2 and a/APO2 significantly improved after surfactant treatment. The adjusted odds ratio for the need of MV and the adjusted differences of duration of noninvasive respiratory support, and of NICU and hospital stay were not different in the surfactant and non-surfactant groups. Conclusions: Surfactant therapy was followed by a quick and persisting significant improvement of respiratory function in late preterm infants with RDS. Surfactant did not improve short-term outcomes in our population probably because other factors such as the gestational age, occurrence of complications and poor feeding play a relevant role.

AB - Objective: To evaluate surfactant effectiveness for the treatment of respiratory distress syndrome (RDS) in late preterm infants. Methods: We performed a retrospective cohort study of infants born between 34+0 and 36+6 weeks of gestation admitted for respiratory failure in seven perinatal centers from January 2010 to December 2014. We evaluated changes of FiO2, PaO2 and a/APO2 in surfactant-treated patients, and the need and duration of MV, the duration of noninvasive respiratory support, stay in NICU and in hospital in surfactant-treated and untreated late preterm infants with RDS alone. Results: We studied 562 infants with RDS, 252 (45%) were treated with surfactant and 310 (55%) were not. FiO2, PaO2 and a/APO2 significantly improved after surfactant treatment. The adjusted odds ratio for the need of MV and the adjusted differences of duration of noninvasive respiratory support, and of NICU and hospital stay were not different in the surfactant and non-surfactant groups. Conclusions: Surfactant therapy was followed by a quick and persisting significant improvement of respiratory function in late preterm infants with RDS. Surfactant did not improve short-term outcomes in our population probably because other factors such as the gestational age, occurrence of complications and poor feeding play a relevant role.

KW - infant

KW - Late preterm

KW - respiratory distress syndrome

KW - surfactant

UR - http://www.scopus.com/inward/record.url?scp=85018170028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018170028&partnerID=8YFLogxK

U2 - 10.1080/14767058.2017.1313828

DO - 10.1080/14767058.2017.1313828

M3 - Article

C2 - 28367650

AN - SCOPUS:85018170028

VL - 31

SP - 1259

EP - 1266

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 10

ER -